Engineering

Stanford Bio-X Frontiers in Interdisciplinary Biosciences Seminar, "Time to change a paradigm: non-specific effects of vaccines"

Sponsored by Bio-X Program

When

Thursday, May 23, 2019
4:00 pm – 5:00 pm
Add to my calendar

Where

Clark Center Seminar Room S360
Open in map

Contact via email
Contact via phone

650-725-7472

This event is open to:
Everyone

Admission
See event details for admission info.

Event Details:

Stanford Bio-X Frontiers in Interdisciplinary Biosciences Seminar

Speaker: Christine Stabell-Benn, Bandim Health Project, Statens Serum Institut

Seminar Title: "Time to change a paradigm: non-specific effects of vaccines"

Hosted by: Dr. Annelise Barron, Associate Professor of Bioengineering, Stanford University

Abstract:

Unknown to most people, vaccines were never tested for their effects on overall health before being introduced. Everybody was so certain that vaccines only affect the target infection that it did not seem necessary. Our population-based epidemiological studies in one of the world’s poorest countries, Guinea-Bissau, have now revealed that this assumption is too simplistic. In this setting, with a very high infectious disease mortality, it became clear that vaccines not only protect against the target infection, they also affect the susceptibility to other infections. We have called these effects the “non-specific effects” of vaccines. Live vaccines (e.g. against measles, polio, tuberculosis and smallpox) increase the resistance towards many other infections. Worryingly, non-live vaccines (e.g. against diphtheria, tetanus, pertussis and hepatitis B) increase the susceptibility to other infections and the overall effect may be negative; this, however, may be circumvented by providing live vaccines afterwards. Immunological studies are now providing a biological mechanism by showing that vaccines modulate the innate immune system. These findings challenge our understanding of vaccines and the immune system. The implications are far-reaching: hundreds of thousands of lives could be saved every year in low-income countries and morbidity and health expenditure could be reduced significantly in high-income countries, simply by using the existing vaccines smarter.

Visit this website for more information